Medical/Pharmaceuticals
Brii Biosciences Exercises Option for Vir Biotechnology's VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China
Exclusive development and commercialization rights to VIR-3434 in China strengthen Company's leadership and robust clinical pipeline in HBV Key partnership with Vir enables multitude of combination treatment options as part of Company's strategic approach to developing a functional cure for HBV ...
2022-07-04 07:10
4853
GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia
Building public trust and educating on the importance of getting vaccinated KUALA LUMPUR, Malaysia, July 1, 2022 /PRNewswire/ -- GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, technology an...
2022-07-01 09:16
3739
Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS
GOTHENBURG, Sweden, July 1, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) ("Mentice") Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on9th June 2022, now has been completed. The information was submitted for re...
2022-07-01 03:42
3563
Tencent Cloud and Millennium Technology Services Roll Out i-Care to Connect Patients, Families and Caregivers, Delivering Seamless Comfort Care Anytime, Anywhere
The Tencent Cloud-backed solution aims to help improve patients' experience and quality of life SINGAPORE, June 30, 2022 /PRNewswire/ -- Customers' habits and expectations have evolved dramatically over the last few years across various industries including the medical and healthcare field, driv...
2022-06-30 22:00
5858
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover
HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...
2022-06-30 20:43
5021
Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
- Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend treatmen...
2022-06-30 19:00
3086
Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK
MELBOURNE, Australia, June 30, 2022 /PRNewswire/ -- UK consumers will again be able to buy VIRALEZE™, an easy-to-use barrier nasal spray, from LloydsPharmacy, following its relaunch online, with instore availability to follow shortly. Extensive antiviral testing undertaken at the globally renowne...
2022-06-30 12:41
2465
DigiconAsia readers honor Asia Pacific's digital innovators
The inaugural DigiconAsia DX Solution Excellence Awards
2022-06-30 12:00
5197
Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan
SHANGHAI, June 30, 2022 /PRNewswire/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabi...
2022-06-30 08:00
4624
Insurance providers can assess customer health risks in real-time using contactless vital sign monitoring solution from NuraLogix
LAS VEGAS, June 29, 2022 /PRNewswire/ -- Insurance providers are now able to evaluate customer health risks in real-time using a revolutionary contactless wellness and vital sign monitoring solution fromNuraLogix. The application allows insurance providers to quickly perform a customer health ...
2022-06-29 21:05
2963
BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures
NEW YORK, June 29, 2022 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client,BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has successfully entered into a co-development agreement withGenFleet Therapeutics, Inc., an immuno-oncology focused biopharmaceutical company b...
2022-06-29 20:00
4370
Positive data from the clinical phase I MAD study with AlzeCure's Alzheimer's project NeuroRestore ACD856
STOCKHOLM, June 29, 2022 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced th...
2022-06-29 19:32
2449
Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution
SEOUL, South Korea, June 29, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible with the company's fully automated 'AIOS' (All-in-One System). This is ...
2022-06-29 19:00
2839
Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic
GOTHENBURG, Sweden, June 29, 2022 /PRNewswire/ -- Mentice, Gothenburg (STO: MNTC), a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic,Dublin (NYSE: MDT), a global healthcare technology leader, has signed an agreement to acquire Mentice...
2022-06-29 14:37
2093
Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forward
LONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential
Skin Ltd
2022-06-29 08:32
3024
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
SAN FRANCISCO and SUZHOU, China, June 29, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2022-06-29 08:00
4079
NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe
- Combines NewAmsterdam's lead clinical program obicetrapib with Menarini's deep cardiovascular disease and regional expertise - Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net pro...
2022-06-29 00:53
3916
OME Health, a UK-based DIGITAL health company, announces the launch of a novel health and nutrition coaching platform on the heels of a new funding round
LONDON, June 28, 2022 /PRNewswire/ -- OME Health recently closed a new funding round led by Gen-tech Investments, with the participation of global pharmaceutical company Bayer AG, leading athletics company ASICS Ltd., and existing investors. The company also launched a B2B nutrition and health c...
2022-06-28 21:56
2826
Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies
* Palleon and Henlius to co-develop Bifunctional HER2-Sialidase and a second bifunctional sialidase to be jointly designed - * Henlius received exclusive license for two products in China (including Hong Kong, Macau, and Taiwan); Palleon retains all other global rights - * Palleon receives u...
2022-06-28 21:50
4599
New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos
SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- Human Reproduction journal has published the ground-breaking results of an international clinical study, where a novel AI algorithm called Life Whisperer Genetics was developed by AI healthcare company Presegen to assess the genetic integrity of embryo...
2022-06-28 19:07
2217
Week's Top Stories
Most Reposted
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
[Picked up by 294 media titles]
2026-10-22 22:35
TCL Zhonghuan Powers India's Energy Transition with PV Innovations at REI Expo 2026
[Picked up by 281 media titles]
2026-10-23 21:52
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 278 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 271 media titles]
2026-10-22 11:55Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan
[Picked up by 270 media titles]
2026-10-23 19:08
Most Read
Hi3D V1.0 Goes Open Source: The First Production-Validated Open-Source AI 3D Model
2026-10-23 23:30
32958
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
30385
BeautyPlus Web Launches Halloween Photo Booth With Behind-the-Scenes Video Export
2026-10-23 01:00
28057
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
25879
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
2026-10-21 15:00
13999